These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2011892)

  • 21. Primary risk factors influence risk of recurrent myocardial infarction/death from coronary heart disease: results from the Stockholm Heart Epidemiology Program (SHEEP).
    Leander K; Wiman B; Hallqvist J; Andersson T; Ahlbom A; de Faire U
    Eur J Cardiovasc Prev Rehabil; 2007 Aug; 14(4):532-7. PubMed ID: 17667644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some factors influencing the prognosis of patients after myocardial infarction.
    Kolesár J; Mikes Z; Dukát A; Petrovicová J; Brveník P; Stukovský R; Gregorová M
    Cor Vasa; 1982; 24(1):38-46. PubMed ID: 7067463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The open artery hypothesis: beneficial effects and long-term prognostic importance of patency of the infarct-related coronary artery.
    Centurión OA
    Angiology; 2007; 58(1):34-44. PubMed ID: 17351156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The outcome and course of IHD in patients with normal and altered coronary arteries under 10-15 years of observation].
    Laane PG; Shipilova TV
    Ter Arkh; 1995; 67(7):69-71. PubMed ID: 7482312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Rehabilitation results with patients having had a myocardial infarct].
    Sledzevskaia IK; Karbovnichaia NM; Il'iash MG
    Vrach Delo; 1989 Mar; (3):7-9. PubMed ID: 2750128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival analysis within one year of first acute myocardial infarction: comparison between non-Q and Q wave myocardial infarction.
    Caires G; Pereira D; Freitas AD; Teixeira F; Leite R; Araújo JJ; Cardoso A; Pereira AC; Macedo ME; Diniz M
    Rev Port Cardiol; 2000 Dec; 19(12):1223-38. PubMed ID: 11220119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inderal in the acute and post-myocardial infarct periods].
    Popov VG; Martynov IV; Alushkov MV; Voronin VA
    Ter Arkh; 1986; 58(6):53-8. PubMed ID: 3764715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Two year follow-up of acute ischemic syndrome without ST elevation].
    Tan HQ; Zhu J; Liang Y; Zhang Y; Liu LS;
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):184-8. PubMed ID: 15854465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Histological, histochemical and x-ray angiographic studies of the blood circulation in the myocardium in cardiac infarct].
    Gegova A
    Vutr Boles; 1977; 16(1):78-82. PubMed ID: 898916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The age-related characteristics of the cardiodynamics of patients who have had a myocardial infarct].
    Sledzevskaia IK; Il'iash MG; Stroganova NP; Karbovnichaia NM; Golovkov IuZh
    Vrach Delo; 1991 Oct; (10):43-5. PubMed ID: 1803744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of the depth of myocardial infarction on the tolerance to physical exertion and hemodynamics in patients in the early rehabilitation period].
    Baĭdun S
    Vrach Delo; 1991 Jun; (6):33-6. PubMed ID: 1891845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Enterosorbent SKN in the combined rehabilitative treatment of patients who have had a myocardial infarct].
    Sledzevskaia IK; Bul'da VI; Babov KD
    Vrach Delo; 1991 Sep; (9):87-9. PubMed ID: 1759442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of infarct size limitation by propranolol on ventricular arrhythmias after myocardial infarction.
    Stewart JR; Gibson JK; Lucchesi BR
    Ann N Y Acad Sci; 1982; 382():223-8. PubMed ID: 7044241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Problems in the use of cardiac glycosides in ischemic heart disease].
    Modersohn D; Urbaszek W
    Z Gesamte Inn Med; 1975 Aug; 30(15):502-6. PubMed ID: 1189495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Physiological aspects and pharmacological approaches for preservation of ischemic myocardium in acute myocardial infarction].
    Schlesinger Z
    Harefuah; 1976 Aug; 91(3-4):86-9. PubMed ID: 976845
    [No Abstract]   [Full Text] [Related]  

  • 36. [The efficacy of glucosamine in treating complicated hyperreactive experimental myocardial infarct].
    Sokrut VN; Zupanets IA; Iabluchanskiĭ NI; Drogovoz SM
    Farmakol Toksikol; 1991; 54(2):31-3. PubMed ID: 1653152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tolerance and hemodynamic support for physical loading in patients in the early period of an acute large-focus myocardial infarct].
    Al'khimovich VM; Rusetskaia VG; Rudina MD; Golubev VG
    Kardiologiia; 1985 Feb; 25(2):11-4. PubMed ID: 3990072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The hemodynamic and prognostic effects of a past myocardial infarct on the natural course of ischemic heart disease].
    Aschermann M; Jezek V; Vancura J
    Cas Lek Cesk; 1978 Oct; 117(41):1282-6. PubMed ID: 719681
    [No Abstract]   [Full Text] [Related]  

  • 39. [Microfocal myocardial infarct as a variant of exacerbation of ischemic heart disease].
    Popov VG; Rozova NK; Pogrebnaia NA; Meshalkin LD; Suvorova LV
    Kardiologiia; 1979 Oct; 19(10):27-31. PubMed ID: 502164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of inosine on the course of myocardial infarct].
    Nikolaeva LF; Lysenko LT; Makarova TE
    Klin Med (Mosk); 1975 Jul; 53(7):50-6. PubMed ID: 1206993
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.